1,3-Bis(2,6-diisopropylphenyl)-1,3,2-diazaphospholidine 2-Oxide, 97%, 10g

2-[2-Hydroxyethyl(phenylmethyl)amino]ethanol, 95.0%, 5g

(S)-1-((S)-3-(Acetylthio)-2-methylpropanoyl)pyrrolidine-2-carboxylic acid, 95.0%, 5g

1-(2-(Methylthio)pyrimidin-4-yl)ethanone, 95.0%, 25g

(5-Hydroxy-2-(trifluoromethoxy)phenyl)boronic acid, 98%, 10g

2-(1-Methyl-1H-imidazol-4-yl)acetonitrile, 97%, 100mg

GC capillary column ROTI®Cap-5, 25 m, 0.20 mm, 0.50 µm, 1 Piece(s)

2-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)acetic acid, 95.0%, 1g

BUTYL 6-BROMO-4-(PYRROLIDIN-1-YL)QUINOLINE-2-CARBOXYLATE, 95.0%, 250mg

4-(Trifluoromethyl)-2h,3h,5h,6h,7h-cyclopenta[c]pyridazin-3-one, 98%, 100mg

N-(3-Aminomethyl-phenyl)-2-(4-hydroxy-phenyl)-acetamide, 97.0%, 5g

2-[[(1S)-1-(3-BUTYN-1-YL)HEXYL]OXY]TETRAHYDRO-2H-PYRAN, 95.0%, 5g

(2-(4-Vinylphenyl)ethene-1,1,2-triyl)tribenzene, 97%, 1g